Press release
Global SCN8A Community Unites for Awareness: Recognizing the Unseen Struggle on International SCN8A Awareness Day
On February 9, 2024, the global SCN8A community will come together to observe International SCN8A Awareness Day, an event dedicated to shedding light on SCN8A, a rare neurological disorder. This year's theme, "If You Only Knew," aims to reveal the hidden challenges faced by individuals and families affected by SCN8A and to foster a deeper understanding and support network for them.SCN8A mutations are linked to severe epilepsy and developmental issues, impacting numerous lives worldwide. Despite its significant impact, SCN8A remains under-recognized. This awareness day seeks to change that by educating the public, healthcare professionals, and policymakers about the disorder.
The SCN8A Awareness Day is more than an event; it's a vital platform for change. "If only more people knew about SCN8A, early diagnosis and effective treatment would be more attainable, and families would feel less isolated," says Kacie Craig, Executive Director of The Cute Syndrome Foundation. "This day is about turning empathy into action and ensuring that individuals living with SCN8A receive the recognition and support they deserve."
February 9th will mark what would have been the 28th birthday for Shay Hammer whose father Michael, at the time a population geneticist, was the first to isolate the SCN8A gene as the cause of his daughter's struggle with epilepsy. Sadly, the discovery came weeks after Shay's sudden and unexpected death in 2011 at 15 years old - the first documented case of SUDEP (Sudden Unexplained Death in Epilepsy) in a child with an SCN8A mutation.
We invite rare disease organizations, media outlets, healthcare professionals, educators, and the public to join us in this important cause. Together, we can shine a light on SCN8A and make a tangible difference in the lives of those affected.
For more information about International SCN8A Awareness Day and how to get involved, please visit scn8aawarenessday.net or contact Kacie Craig (executivedirector@thecutesyndrome.com).
ABOUT SCN8A
SCN8A is a gene that affects how brain cells function. Mutations on this gene cause a range of symptoms that can include severe epilepsy, developmental delay, and other medical challenges. Every person with this condition is affected differently and with varying severity. The role of SCN8A in the human brain was discovered in 2012. Since then, ~550 patients have been diagnosed with SCN8A epilepsy and related disorders. Due to advances in genetic testing, more patients are being discovered all the time.
Little is known about SCN8A including an absence of established treatments. Like many rare disorders, families and their efforts to advance research offer the greatest hope for these beautiful children who deserve answers.
The Cute Syndrome Foundation
PO Box 842
Ozark, MO 65721
Kacie Craig, Executive Director
executivedirector@thecutesyndrome.com
thecutesyndrome.com
The Cute Syndrome Foundation raises awareness of SCN8A mutations, funds the dedicated and talented scientists researching SCN8A, and supports families around the world who are affected by this disorder. Our commitment to raising awareness and supporting research for SCN8A is driven by our belief in a future where every individual with SCN8A has access to the best possible care and support.
The Cute Syndrome Foundation is the starting point for support for new families to reach as they receive a diagnosis. We help clinicians standardize treatment for individuals with SCN8A. We work to expand scientific knowledge of rare genetic mutations associated with pediatric epilepsy and are the mainstay foundation to increase public knowledge of SCN8A mutations.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global SCN8A Community Unites for Awareness: Recognizing the Unseen Struggle on International SCN8A Awareness Day here
News-ID: 3357478 • Views: …
More Releases for SCN8A
Encephalopathy Pipeline Insight, 2025: Innovative Therapies Target Complex Pathw …
Encephalopathy refers to a broad spectrum of neurological disorders characterized by altered brain function or structure due to various causes such as metabolic imbalances, infections, toxins, trauma, and liver or kidney failure. Given its heterogeneous nature and high morbidity, encephalopathy remains a challenging condition to treat, with limited targeted therapies currently available across subtypes like hepatic, hypoxic-ischemic, uremic, and Wernicke's encephalopathy.
As of 2025, the encephalopathy treatment pipeline is expanding with…
Encephalopathy Pipeline and Clinical Trials Assessment 2023: FDA Approvals, Ther …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Encephalopathy pipeline constitutes 70+ key companies continuously working towards developing 70+ Encephalopathy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Encephalopathy Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Encephalopathy Market.
The Encephalopathy Pipeline report embraces in-depth…